VANGUARD GROUP INC 13D and 13G filings for Mirati Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | Mirati Therapeutics, Inc. MRTX | VANGUARD GROUP INC | 5,306,693 7.570% | 332,805 (+6.69%) | Filing |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | Mirati Therapeutics, Inc. MRTX | VANGUARD GROUP INC | 4,973,888 8.640% | 534,911 (+12.05%) | Filing |
| 2022-02-10 08:27 am Purchase | 2021-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | VANGUARD GROUP INC | 4,438,977 8.040% | 406,739 (+10.09%) | Filing |
| 2021-02-10 11:28 am Purchase | 2020-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | VANGUARD GROUP INC | 4,032,238 7.920% | 964,627 (+31.45%) | Filing |